Market Overview
The Global Functional Electrical Stimulation Market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period 2024-2031.
Functional electrical stimulation (FES) is a treatment that involves painless, mild electrical stimulation to a muscle or muscles to help them move. Functional Electrical Stimulation helps initiate muscle activity by stimulating the muscles to strengthen muscle activity to reduce muscle spasticity.
FES stimulates the motor nerves to achieve muscle contraction. It is used widely in rehabilitation and maintenance of function where there is muscle weakness or tightness. FES applies low-level electrical impulses to weakened, damaged, or paralyzed muscles to help improve people’s capability and mobility.
Market Scope
| Metrics | Details |
| CAGR | YY% |
| Market Size | 2022-2031 |
| Market Estimation Forecast Period | 2023-2031 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Product Type, Device Type, Application, End-User |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
For more details on this report – Request for Sample
Market Dynamics: Drivers & Restraints
Innovations in functional electrical stimulation systems for spinal cord injuries
The increase in innovations and increase in the launch of advanced devices is expected to drive market growth.
For instance, in July 2023, Motive Health introduced the US Food and Drug Administration (FDA)-approved Motive Knee muscle stimulation device.
For instance, in July 2022, Healthtech startup Pulsetto launched a neuromodulation device that stimulates the vagus nerve. Stimulating the vagus nerve with electric impulses activates the parasympathetic nervous system by allowing the body to rest and relax.
Additionally, an increase in chronic pain and the increase in neuromuscular injuries and spinal cord injuries is also expected to drive market growth.
Restraint
Stringent regulations for device approvals
Long approval processes are causing delays in introducing new items to the market. Stringent device licensing regulations and a wide choice of electrical stimulation system alternatives are the factors the market is expected to get hampered in the forecast period.
Additionally, the high cost of the devices and the risks associated with the treatment procedures are expected to hinder market growth.
Segment Analysis
The global functional electrical stimulation market is segmented based on product type, device type, application, end-user and region.
Spinal cord stimulation devices segment accounted for 45.2% of the market share
Spinal cord stimulation uses a mild electrical current to stimulate certain nerve fibers in the spinal cord. Spinal cord stimulation helps in targeted pain relief. The increase in the number of spinal cord injuries and increase in the number of stimulation devices is expected to drive the segment growth.
For instance, in January 2021, Boston Scientific introduced the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) systems.
In December 2022, Abbott launched the world's smallest implantable, rechargeable spinal cord stimulation system for chronic pain. Thus, the increase in the number of spinal cord injuries increases the demand for spinal cord stimulation devices.
Geographical Analysis
North America is expected to hold a significant position in the global functional electrical stimulation market share
North America accounted for the largest market share. The increasing prevalence of chronic pain and increasing injuries and increase in the number of individuals preferring rehabilitation centers is expected to hold the region in the dominant position. Additionally, increasing technological advancements and increasing manufacturing of medical devices are also expected to raise the market growth in the region.
For instance, according to the Centers for Disease Control and Prevention, it is estimated that in 2021, 20.9% of U.S. adults i.e., 51.6 million individuals experienced chronic pain, and 6.9% i.e., approximately 17.1 million individuals experienced high-impact chronic pain.
According to the CDMRP report, it is estimated that there are serious injuries with long-term consequences requiring lifelong care. It is estimated that about 300,000 individuals are living with an SCI, and over 17,000 new cases occur in the U.S. each year. Thus, the above factors are expected to raise the market growth.
COVID-19 Impact Analysis
COVID-19 has had an unprecedented impact on manufacturing companies and the health sector, this is due to the restrictions imposed during the COVID-19 period. Lockdown has created a major challenge in supplying the devices across borders due to the restrictions imposed by the governments and the lack of labor during the period has also affected the market growth.
Competitive Landscape
The leading companies with a significant market share include Boston Scientific Corporation, AxioBionics Inc., Nevro Corp, Medtronic Plc, NeuroMetrix, Inc., BTL Industries, Inc., Zynex Inc., Abbott Laboratories, Hocoma AG, OMRON Healthcare among others
Key Developments
- In December 2022, the U.S. Food and Drug Administration (FDA) approved Abbott's Eterna spinal cord stimulation (SCS) system for the treatment of chronic pain
- In January 2022, Bioelectronics company NeuroSigma Inc. commercially launched a bioelectronic medical device that uses external trigeminal nerve stimulation (eTNS) to treat children with attention deficit/hyperactivity disorder (ADHD).
- In September 202, Evolution Devices launched its EvoWalk Platform pilot program to rehabilitate walking for people living with neurologically-based partial walking paralysis.
Why Purchase the Report?
- To visualize the global functional electrical stimulation market segmentation based on product type, device type, application, end-user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of functional electrical stimulation treatment market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global functional electrical stimulation market report would provide approximately 69 tables, 75 figures, and 180 Pages.
Target Audience 2023
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
